FDA grants quick review for 3 psychedelic drug trials

The Food and Drug Administration granted a quick review of three experimental psychedelic drugs meant to treat major depression and post-traumatic stress disorder. NBC News' Erika Edwards reports on the specific drugs under review and how the FDA determines whether they are safe and effective.